Advances in metabolomics and lipidomics are generating unprecedented volumes of complex data, but confident identification and biological interpretation of small molecules remain significant challenges. Limitations in annotation, data dimensionality, and reproducibility can slow discovery and reduce confidence in downstream decision making across clinical, translational, and applied research.
In this live broadcast event, leading experts explore how next generation mass spectrometry technologies, ion mobility, and computational tools are helping researchers move from complex datasets to confident insight. Through three short, focused scientific talks, speakers will share real world examples of how multi dimensional data and advanced workflows are being used to improve metabolite and lipid annotation, accelerate small molecule discovery, and enable more robust and reproducible analyses.
PD Dr. Michael Witting, Deputy Head Metabolomics and Proteomics Core & Executive Manager Metabolomics, Helmholtz Munich, Munich, Germany
Pieter Dorrestein, Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences Departments of Pharmacology and Pediatrics, UC San Diego, San Diego, CA, USA
Pelle Simpson, Principal Scientist, Enveda, Boulder, CO, USA
For Research Use Only. Not for use in clinical diagnostic procedures.